Crosstalk between the coagulation and complement systems in sepsis

  • Lupu F
  • Keshari R
  • Lambris J
 et al. 
  • 64


    Mendeley users who have this article in their library.
  • 18


    Citations of this article.


Sepsis is a potent activator of the hemostatic and complement systems. While local activation of these proteolytic cascades contributes to the host defense, their uncontrolled systemic activation has major tissue damaging effects that lead to multiple organ failure and death. We have extensively studied the activation of complement and coagulation cascades in experimental sepsis using baboons challenged with live bacteria, such as Gram-negative Escherichia coli or Gram-positive Staphylococcus aureus and Bacillus anthracis, or with the bacterial product peptidoglycan. We observed that these challenges rapidly induce disseminated intravascular coagulation and robust complement activation. We applied a potent C3 convertase inhibitor, compstatin, which prevented sepsis-induced complement activation, reduced thrombocytopenia, decreased the coagulopathic responses, and preserving the endothelial anticoagulant properties. Overall, our work demonstrates that live bacteria and bacterial products activate the complement and coagulation cascades, and that blocking formation of complement activation products, especially during the organ failure stage of severe sepsis could be a potentially important therapeutic strategy. © 2014 Elsevier Ltd. All rights reserved.

Author-supplied keywords

  • Coagulation
  • Complement
  • Disseminated intravascular coagulation
  • Inflammation
  • Multiple organ failure
  • Sepsis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Florea Lupu

  • Ravi S. Keshari

  • John D. Lambris

  • K. Mark Coggeshall

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free